Indocyanine Green Fluorescence Angiography for Intraoperative Assessment of Blood Flow: A Feasibility Study  by Unno, N. et al.
Eur J Vasc Endovasc Surg 35, 205e207 (2008)
doi:10.1016/j.ejvs.2007.09.001, available online at http://www.sciencedirect.com onSHORT REPORTIndocyanine Green Fluorescence Angiography for Intraoperative
Assessment of Blood Flow: A Feasibility Study
N. Unno,1,2* M. Suzuki,1,2 N. Yamamoto,1,2 K. Inuzuka,1,2 D. Sagara,1,2
M. Nishiyama,1,2 H. Tanaka1,2 and H. Konno2
1Division of Vascular Surgery and 2Second Department of Surgery, Hamamatsu University School of





1078–5Objective. To introduce our preliminary experience with indocyanine green (ICG) fluorescence angiography for the assess-
ment of lower leg bypasses.
Methods. 1 ml of 0.5% indocyanine green was intravenously injected in 9 patients with PAD who underwent paramal-
leolar artery bypass using saphenous vein grafts. A newly developed near-infrared camera system (PDE; Hamamatsu
Photonics K.K. Hamamatsu, Japan) was used for this study.
Results. ICG fluorescence angiography was performed without any adverse events. Fluorescence images of ICG angiog-
raphy could be viewed as real-time images of the angiography in eight patients, while one patient underwent graft revision
with the absence of fluorescence in ICG angiography.
Conclusion. ICG fluorescence angiography is clinically feasible and may help surgeons assess the quality of lower leg by-
passes.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The intraoperative assessment of graft patency is partic-
ularly important in vascular surgery. Recently, some
studies have reported the usefulness of indocyanine
green (ICG) e based intraoperative fluorescent angiog-
raphy in coronary arterybypass1 andneurovascular sur-
gery.2 In this study, we reported our initial experience of
ICG angiography following peripheral bypass.Patients and Methods
This study included 9 patients with critical limb
ischemia (6 patients with foot ulcers, 3 patients with
rest pain) who underwent paramalleolar artery bypass
using saphenous vein grafts (femoro-anterior tibialsponding author. N. Unno, MD, Division of Vascular Surgery,
Department of Surgery, Hamamatsu University School of
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6 (Fig. 1A), five men, four women, mean age:
69.5 10.0 years). All bypass operations were per-
formed by one attending vascular surgeon. Patients
were interviewed regarding a history of iodine allergy,
pregnancy, or previous anaphylactic reactions to con-
trast media. With approval of the ethical committee
and written informed consent, ICG fluorescence angi-
ography was performed. After completion of the by-
pass anastomoses, 1 ml of ICG (Diagnogreen 0.5%;
Daiichi Pharmatical, Tokyo, Japan) was intravenously
injected via a central venous line by an anesthesiologist.
ICG dye reached the leg artery about 30 seconds after
the injection. Intravenously injected ICG binds to
circulating globulins and remains intravascular. After
binding to the globulins, ICG absorbs light in the
near-infrared range, with a maximum at 805 nm. ICG
fluoresces with a maximum at 840 nm in plasma.3 We
utilized a newly developed near infrared camera
system (PDE;Hamamatsu PhotonicsK.K.Hamamatsu,
Japan) that activates ICGwithemitted light (wavelength:
760 nm).4 A vascular surgeon directly handled ther Surgery. Published by Elsevier Ltd. All rights reserved.
Fig. 1. Femoro-posterior tibial artery bypass using a reversed saphenous vein graft. A. Photograph taken after the comple-
tion of the bypass reconstruction. B. Intraoperative ICG fluorescence angiogram showing the blood flow from the proximal
to distal anastomosis. C. Postoperative DSA image of the bypass demonstrating the graft patency without stenosis.
206 N. Unno et al.camera unit of the device, and observed real-time images
on the monitor of a laptop computer.
Results
No adverse events relating to ICG angiography were
experienced. All processes including preparation of
the device, injection of ICG, and observation of fluores-
cent images took less than ten minutes. In eight cases,
ICG angiography showed good fluorescent signals as
the ICG passed through the graft from the proximal
to distal anastomoses (Fig. 1B), in which postoperative
DSA confirmed the graft patency (Fig. 1C).However, in
one case, therewas nofluorescence detected in the graft
(posterior tibial artery bypass) at the distal anastomosis
(Fig. 2). Continuous-wave Doppler ultrasound sug-
gested graft failure. During graft revision thrombotic
occlusion of the distal anastomosis was identified.Fig. 2. Failed femoro-posterior tibial artery bypass. No fluo-
rescence is seen in the vein graft at the distal anastomosis
(arrow).Discussion
Although Intraoperative completion angiogram can
provide clear and informative images, it requires radi-
ation shielding and a radiographer. Moreover, the
contrast is nephrotoxic. On the other hand, ICG has
been widely used in a variety of clinical situations
such as examination of hepatic function, and retinalEur J Vasc Endovasc Surg Vol 35, February 2008angiography. ICG is a safe compound with minor
side effect. For patients allergic to iodine, symptoms
such as urticaria or fever may occur. ICG is removed
exclusively by the liver so that it can be used for pa-
tients with renal insufficiency.
The cost of ICG was around 5 EURO per angio-
gram. The newly developed near infrared camera sys-
tem is currently commercially available at around
207ICG Fluorescence Angiography20,000w 25,000 EURO in Japan. The technique can be
performed without any training. Therefore, ICG angi-
ography is easy to introduce into clinical practice.
We experienced one case requiring graft revision, in
which the initial bypass did not show any fluorescence
signals at the distal anastomosis. The graft revision
identified that the failure was attributed to thrombotic
occlusion of the distal anastomosis. The other eight
cases showed good fluorescent signals after revascular-
ization, in which patency was later confirmed with
postoperative DSA. No technical problems such as
retained valve cusp or intimal flap were revealed.
However, abnormal fluorescent signal patterns due to
such technical defects are yet to be identified. Further
study is needed to identify such abnormal patterns.References
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